REUTERS: British drugmaker Vectura Group Plc said on Saturday that it won a patent infringement litigation case against GlaxoSmithKline Plc in the United States and has been awarded US$89.7 million in damages for the period from August 2016 through December 2018. A jury trial in a Delaware ...
from Latest http://bit.ly/2H35mr7
UK's Vectura wins patent infringement case against GlaxoSmithKline in U.S
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment